Current Urology Reports. TVT Secur Ethicon, Somerville, NJthe first mini sling available for use, offers a minimally invasive approach to the surgical treatment of stress incontinence, with its greatest benefit being reduced patient discomfort in the immediate postoperative period. Although little data are available regarding the safety and efficacy of this new generation of slings, TVT Secur appears to be relatively safe.
Jump to navigation. Stress urinary incontinence leakage of urine on effort or exertion, or on coughing, sneezing or laughing is a common condition that affects up to one in three women worldwide. It is usually the result of weakening of the muscular support of the pipe that conducts urine urethraor weakening of the sphincter circular muscle at the base of the bladder, which maintains continence.
By clicking register, I agree to your terms. All rights reserved. Design by w3layouts. Study design: Randomized, single blind, controlled study conducted in two tertiary urogynecological centers.
The transobturator tape TOT method is the recent minimally invasive midurethral sling surgery. The TOT method was invented to reduce complication rate of surgical technique for female stress urinary incontinence. Pelvic bleeding following TOT procedure, although extremely rare, could be occurred.
Over the years with so many different manufacturers pushing these medical devices onto the market we need to re-evalute the true picture. Why am I concerned? They have tried to confuse us all on the word TVT most of us thought TVT is the same product throughout the years when in fact there are different products on the market.
A literature review was performed to identify all published trials of TVT-Secur. We found that TVT-Secur had significant reductions in operative time, visual analog score for pain, and postoperative complications compared with TVT-O. This meta-analysis indicates that TVT-Secur did not show an inferior efficacy and safety compared with TVT-O for SUI in 3 to 5 years, even though displaying a clear tread toward a lower efficacy in 1 to 3 years. Considering that the safety is similar, there are no advantages in using TVT-Secur.
InEthicon Inc. For device licensing, no new evidence of TVT Secur efficacy and safety was needed: rather evidence was provided of the long-term follow-up of patients who had a procedure using a predecate retropubic tension-free vaginal tape device. Before adopting TVT Secur into our routine clinical practice, we decided to evaluate it.